Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab
Clinical trial NCT04255056 · UNKNOWN
Trial details
- NCT number
- NCT04255056
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2021-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.